Clinical Trials Browser

Phase 2 × Skin Neoplasms × Imatinib Mesylate × Clear all

NCT00027586 2018-10-31

Imatinib Mesylate in Treating Patients With Metastatic Melanoma

Phase 2 Completed

Melanoma, Skin Neoplasms